Navigation Links
Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces,a Broad, Patient-Specific Antibody Response

ne, Inc., which is developing gene therapies for neurodegenerative disorders. Cell Genesys is headquartered in South San Francisco, CA and has its principal manufacturing operation in Hayward, CA. For additional information, please visit the company's website at www.cellgenesys.com.

Statements made herein about the company, other than statements of historical fact, including statements about the company's progress, results and timing of clinical trials and preclinical programs and the nature of product pipelines are forward-looking statements and are subject to a number of uncertainties that could cause actual results to differ materially from the statements made, including risks associated with the success of clinical trials and research and development programs, the regulatory approval process for clinical trials, competitive technologies and products, patents, continuation of corporate partnerships and the need for additional financings. For information about these and other risks which may affect Cell Genesys, please see the company's Annual Report on Form 10-K for the year ended December 31, 2006 filed on March 1, 2007 as well as Cell Genesys' reports on Form 10-Q and 8-K and other reports filed from time to time with the Securities and Exchange Commission. The company assumes no obligation to update the forward-looking information in this press release.

Contact: Ina Cu

              Investor Relations

              650-266-3200

CONTACT: Ina Cu, Investor Relations of Cell Genesys, Inc., +1-650-266-3200

Web site: http://www.cellgenesys.com/

Ticker Symbol: (NASDAQ-NMS:CEGE)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer
2. Cell Genesys Provides Final Median Survival Data From Second Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
3. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
4. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
5. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
6. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
7. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
8. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
9. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
10. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
11. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
Post Your Comments:
(Date:12/4/2009)... 4 Bayer Diabetes Care today announced the three grand ... Nick Jonas, of the Jonas Brothers, selected the winning video ... The grand prize is an in-person meeting today with Nick. ... like Nick, are: Caleb, age 6, from Danbury, CT, who ...
(Date:12/4/2009)... Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC Bulletin ... Trademark Office has allowed its patent application on a ... manufacture of the Company,s DCVax® therapeutic cancer vaccines. ... high concentration of dendritic cells (which are the critical ...
(Date:12/4/2009)... anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder ... the comorbidities reported to occur more often in ... epilepsy versus those without an epilepsy diagnosis, according ... the U.S. ,, Findings from " CNS-Related Comorbidities ...
Breaking Medicine Technology:Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3TV Spotlight on DataDeed and Living Will Solutions 57725 1TV Spotlight on DataDeed and Living Will Solutions 57725 2Radiological treatment method spares patients surgery and offers 89 percent cost savings 57721 1Surgeon Battling Own Cancer Developed New Treatment 57718 1Surgeon Battling Own Cancer Developed New Treatment 57718 2Surgeon Battling Own Cancer Developed New Treatment 57718 3
... from CHARM Study in Remission at One Year ... Maintained Remission at Two ... an,open-label extension study of two Abbott pivotal studies, CHARM and ... long-term clinical remission and clinical,response, respectively, according to data presentations ...
... Alba Therapeutics Corporation,announced today that data from ... Clinical Advances in Celiac Disease session at the ... Results of the randomized,double- blind, placebo controlled study ... reactivation by gluten challenge in celiac,subjects in remission(1) ...
Other Medicine Technology:Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 2Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 3Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 4Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 5Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 6Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 7Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 2Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 3Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 4Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 5
(Date:12/5/2009)... helps companies develop and test their cleaning processes. The technology available ... industries and solve problems for customers relating to cleaning parts, process ... ... -- Midbrook, Inc , a Jackson, MI-based company, is home ...
(Date:12/5/2009)... Wind Turbines are popping up in the most unusual places, and to ... , ... (PRWEB) December 5, 2009 -- Who would have thought that ... Inc. of Fort Worth, Texas has announced a new line of turbines, ...
(Date:12/4/2009)... employees came together in more than 90 offices nationwide today, ... audit, tax and advisory firm,s support for literacy with charitable ... long history of volunteerism. Instead of holiday parties, our employees ... for some children," said Tim Flynn, Chairman of KPMG. ...
(Date:12/4/2009)... and Services for the Aging (AAHSA) applauds the Senate for ... provisions remain in the final health reform legislation . The ... with disabilities and their caregivers. ,, We urge the ... make it affordable to care for families and caregivers. , ...
(Date:12/4/2009)... MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and ... Allergan, Inc. (NYSE: AGN ) as ... Inc. (NYSE: BCR ) as its February ... "The committee chose Allergan because of growth opportunities involving its ...
Breaking Medicine News(10 mins):Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2
... Will Discuss the Valecor Platinum(TM) Coronary Stent System ... 14 CorNova Inc. today announced S. Eric ... officer, will present the Valecor Platinum(TM) Coronary Stent ... Glimpse into the Future: Emerging Drug-Eluting Stents ...
... Healthcare has launched the free online board, MedicalMissions.org ( http://www.medicalmissions.org ... around the world. The new website is designed for charitable ... volunteer interests and needs. , ... ...
... TODAY, City-wide Rosters to Include Thousands of ... Influential Doctors by Disease Specialty and Location SANTA FE, ... and predictive modeling company, is launching a new quarterly health ... TODAY. The first-of-its-kind online database provides consumers with access to ...
... at the Advanced Fertility Center of Chicago reveals that women with ... not a correspondingly higher rate of success -- with in-vitro fertilization. ... ... Infertility specialist Richard Sherbahn, MD , and embryologist Ellen Gibbons ...
... Management Health Solutions, Inc. (MHS), a leader in the field of ... today an offer of free data cleansing for all hospitals and ... ... (PRWEB) May 14, 2009-- Management Health Solutions, Inc. (MHS), a leader ...
... Launch of C7XR(TM) FD-OCT Imaging System and Companion ... Mass., May 14 LightLab Imaging Inc., the ... Coherence Tomography (OCT) for vascular and other applications, ... the C7XR FD-OCT Imaging System with the C7 ...
Other Medicine News:Health News:Free Medical Mission 'Job Board' Launched 2Health News:Free Medical Mission 'Job Board' Launched 3Health News:Qforma Launches New Database to Help Consumers Find Top Community Medical Experts 2Health News:Qforma Launches New Database to Help Consumers Find Top Community Medical Experts 3Health News:Chicago-area Infertility Specialist Richard Sherbahn, MD, Reports a Woman's Body Mass Index Affects Her Success in Infertility Treatment 2Health News:Chicago-area Infertility Specialist Richard Sherbahn, MD, Reports a Woman's Body Mass Index Affects Her Success in Infertility Treatment 3Health News:Chicago-area Infertility Specialist Richard Sherbahn, MD, Reports a Woman's Body Mass Index Affects Her Success in Infertility Treatment 4Health News:Management Health Solutions, Inc. Offers Free Data Cleansing 2Health News:Management Health Solutions, Inc. Offers Free Data Cleansing 3Health News:LightLab Imaging Introduces World's Highest Resolution OCT System for Intracoronary Imaging at EuroPCR 2009 2
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
... Durable ergonomic chairs with concave ... support • Select options like seats, ... • Choose the BE Series for ... environments including: industry, education, laboratory, clean ...
... Durable ergonomic chairs with concave ... support • Select options like seats, ... • Choose the BE Series for ... environments including: industry, education, laboratory, clean ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... the BE Series for top performance ... industry, education, laboratory, clean room, static ...
Medicine Products: